PL422982A1 - Universal antigen, universal vaccine against influenza, the system for production of the vaccine, method of production of the antigen and application of the antigen for production of the universal vaccine against influenza - Google Patents
Universal antigen, universal vaccine against influenza, the system for production of the vaccine, method of production of the antigen and application of the antigen for production of the universal vaccine against influenzaInfo
- Publication number
- PL422982A1 PL422982A1 PL422982A PL42298217A PL422982A1 PL 422982 A1 PL422982 A1 PL 422982A1 PL 422982 A PL422982 A PL 422982A PL 42298217 A PL42298217 A PL 42298217A PL 422982 A1 PL422982 A1 PL 422982A1
- Authority
- PL
- Poland
- Prior art keywords
- antigen
- universal
- production
- vaccine
- against influenza
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Przedmiotem zgłoszenia są antygen uniwersalny, uniwersalna szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu i zastosowanie antygenu do wytwarzania szczepionki uniwersalnej przeciwko grypie. Rozwiązanie ujęte w zgłoszeniu prowadzi do uzyskania wysoko immunogennego antygenu co nie wymaga kontaktu z wirusem, a jedynie z genem hemaglutyniny. Przedmiotowa szczepionka charakteryzuje się tym, że nie zawiera wirusa ani jego fragmentów, nie zawiera komórek innych organizmów ani ich fragmentów, a jedynie oczyszczony antygen.The subject of the application is a universal antigen, a universal influenza vaccine, a vaccine production system, a method for producing an antigen and the use of an antigen for the preparation of a universal influenza vaccine. The solution included in the application leads to a highly immunogenic antigen which does not require contact with a virus, but only with the hemagglutinin gene. The vaccine is characterized in that it does not contain the virus or its fragments, it does not contain cells of other organisms or their fragments, but only purified antigen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL422982A PL422982A1 (en) | 2017-09-26 | 2017-09-26 | Universal antigen, universal vaccine against influenza, the system for production of the vaccine, method of production of the antigen and application of the antigen for production of the universal vaccine against influenza |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL422982A PL422982A1 (en) | 2017-09-26 | 2017-09-26 | Universal antigen, universal vaccine against influenza, the system for production of the vaccine, method of production of the antigen and application of the antigen for production of the universal vaccine against influenza |
Publications (1)
Publication Number | Publication Date |
---|---|
PL422982A1 true PL422982A1 (en) | 2019-04-08 |
Family
ID=65992048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL422982A PL422982A1 (en) | 2017-09-26 | 2017-09-26 | Universal antigen, universal vaccine against influenza, the system for production of the vaccine, method of production of the antigen and application of the antigen for production of the universal vaccine against influenza |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL422982A1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015093996A1 (en) * | 2013-12-20 | 2015-06-25 | Instytut Biochemii I Biofizyki Pan | Antigen, influenza vaccine, system for vaccine manufacturing, method of antigen production, and use of antigen to produce an influenza vaccine |
-
2017
- 2017-09-26 PL PL422982A patent/PL422982A1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015093996A1 (en) * | 2013-12-20 | 2015-06-25 | Instytut Biochemii I Biofizyki Pan | Antigen, influenza vaccine, system for vaccine manufacturing, method of antigen production, and use of antigen to produce an influenza vaccine |
Non-Patent Citations (4)
Title |
---|
CREGG J. ET AL., RECOMBINANT PROTEIN EXPRESSION IN PICHIA PASTORIS, 2000 * |
STEEL J. ET AL., INFLUENZA VIRUS VACCINE BASED ON THE CONSERVED HEMAGGLUTININ STALK DOMAIN, 2010 * |
URANOWSKA K. ET AL., HEMAGGLUTININ STALK DOMAIN FROM H5N1 STRAIN AS A POTENTIALLY UNIVERSAL ANTIGEN (ABSTRACT), 2014 * |
URANOWSKA K. ET AL., HEMAGGLUTININ STALK DOMAIN FROM H5N1 STRAIN AS A POTENTIALLY UNIVERSAL ANTIGEN, 2014 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018000232A1 (en) | Peptide mixture (divisional application 201601405) | |
WO2019126634A3 (en) | Targeted integration of nucleic acids | |
WO2018089851A3 (en) | Influenza vaccine | |
PH12018500916A1 (en) | Antibody neutralizing human respiratory syncytial virus | |
BR112017008165A2 (en) | single domain antibodies directed against intracellular antigens | |
EA201890527A1 (en) | THERAPEUTIC VACCINES AGAINST HPV18 | |
PE20160045A1 (en) | SOLUBLE AND STABILIZED RESPIRATORY SYNCITIAL VIRUS (RSV) PREFUSION POLYPEPTIDES F | |
WO2014113490A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
EP4043031A3 (en) | Zika viral antigen constructs | |
ES2721309T3 (en) | Composition for preparing tagatose and method for preparing tagatose from fructose | |
CL2016002794A1 (en) | Peptide vaccine comprising a mutant ras peptide and a chemotherapeutic agent | |
EP3939604A3 (en) | Influenza hemagglutinin protein vaccines | |
CY1119957T1 (en) | TREATMENT OF PATIENTS WITH THE USE OF ANNOUNCED PHARMACEUTICAL PREPARATION | |
BR112019004911A2 (en) | modified oligonucleotides and methods of use | |
MY189495A (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
MX2017016896A (en) | Inactivated canine influenza vaccines and methods of making and uses thereof. | |
MX2016013631A (en) | Modified host cells and uses thereof. | |
PH12020500569A1 (en) | Influenza virus vaccines and uses thereof | |
NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
BR112018069079A2 (en) | live attenuated alphavirus constructs and methods and uses thereof | |
MX2015013304A (en) | Influenza nucleoprotein vaccines. | |
BR112014020025A8 (en) | ROTAVIRUS SUBUNIT VACCINES AND PRODUCTION METHODS AND USE THEREOF | |
EA201400235A1 (en) | VACCINES AGAINST FLU BASED ON H5 | |
RU2016152662A (en) | A microorganism of the genus Escherichia producing L-tryptophan, and a method for producing L-tryptophan using this microorganism | |
MX2019007924A (en) | Influenza vaccines. |